Pilot Study of Intratumoral G100, Toll-Like Receptor-4 (TLR4) Agonist, Therapy in Patients With Merkel Cell Carcinoma (MCC).

Journal of Clinical Oncology - United States
doi 10.1200/jco.2015.33.15_suppl.3083